RAPID CITY, S.D. — Cassandra Palmier had been meaning to get her son the second and final dose of the measles vaccine. But car problems made it difficult to get to the doctor. So she pounced on the opportunity to get him vaccinated after learning that a mobile clinic would be visiting her neighborhood. “I…
Four key predictions for the future of clinical trials, examining how these changes will revolutionize the speed, efficiency, and reliability of bringing life-saving treatments to market. The post Future Trends for Clinical Trials in 2025 and Beyond appeared first on MedCity News.
The insurance giant and Optum parent is forecasting a 2025 medical care ratio roughly a point above last year’s 85.5 percent.
SpringWorks Therapeutics’ Gomekli is now FDA approved for treating tumors caused by the rare genetic disorder neurofibromatosis type 1. The approval comes as SpringWorks has emerged as a potential acquisition target. The post FDA Approval of Drug for Rare Tumors Enables SpringWorks to Challenge AstraZeneca appeared first on MedCity News.
The Trump administration is directing the Department of Health and Human Services to identify about 26 “critical medicines.” The federal government will stockpile active pharmaceutical ingredients for these products, which the administration contends will insulate the U.S. from foreign supplies while also encouraging more domestic API production. The post Trump’s Push for U.S. Drug Manufacturing…
Rebecca Kasen has seen and heard things in recent years in and around Michigan’s capital city that she never would have expected. “It’s a very weird time in our lives,” said Kasen, executive director of the Women’s Center of Greater Lansing. Last November, a group of people were captured on surveillance video early one morning…
For health systems that are already struggling with capacity and access issues, now is the time to consider specific actions to prepare for this season’s coming surge. The post How Health Systems Can Prepare for the Winter Surge with Virtual Care appeared first on MedCity News.
Agreement includes commitment to share financial risk, encouraging FQHCs to work toward improving health outcomes for Medicaid enrollees
Bain Capital’s buyout of Mitsubishi Tanabe Pharma brings a company with a drug portfolio and pipeline in areas such as immunology, central nervous system disorders, and metabolic disease. This business is the pharmaceuticals division of Japanese conglomerate Mitsubishi Chemical Group. The post Bain Capital Broadens Its Biotech Reach With $3.3B Deal for Mitsubishi Tanabe Pharma…
[Sponsored] AI-powered threats are overwhelming outdated IT defenses. Discover why email remains healthcare’s biggest cybersecurity vulnerability and what can be done to address it. The post AI-Driven Email Attacks Are Exploding. Is Your Healthcare Organization at Risk? appeared first on MedCity News.